Literature DB >> 6323516

Hyperprolactinemia in Cushing's disease and Nelson's syndrome.

T Yamaji, M Ishibashi, A Teramoto, T Fukushima.   

Abstract

In an attempt to clarify the pathogenesis of hyperprolactinemia associated with Cushing's disease, PRL secretion was evaluated in 42 patients with hyperadrenocorticism (Cushing's disease, 26; and adrenocortical adenoma, 16) and in 10 patients with Nelson's syndrome. Mild hyperprolactinemia was found in 6 patients with Cushing's disease (23%) and in 5 patients with Nelson's syndrome (50%). In contrast, basal plasma levels of PRL were normal in all of the patients with Cushing's syndrome secondary to adrenocortical adenoma. Injection of TRH unequivocally induced PRL release; however, the responses were blunted in patients with Cushing's disease and in those with Nelson's syndrome who had hyperprolactinemia. Short term administration of dexamethasone, on the other hand, failed to alter PRL secretion in these patients. In 5 patients with Cushing's disease, plasma levels of PRL were reevaluated when they developed a typical clinical picture of Nelson's syndrome after bilateral adrenalectomy. Four patients had a definite increase in PRL levels. Immunohistochemistry of pituitary adenomas surgically removed from 7 patients with Cushing's disease or Nelson's syndrome demonstrated, in 4 of them, the presence of PRL-containing cells as well as ACTH-containing cells. Two of these patients had hyperprolactinemia, which was corrected by the removal of pituitary tumors. These results suggest that hyperprolactinemia is not a fortuitous occurrence in patients with Cushing's disease and could be explained by the concomitant production and secretion of PRL from corticotroph adenomas.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323516     DOI: 10.1210/jcem-58-5-790

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Cushing's disease and pregnancy.

Authors:  Nicoletta Polli; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

2.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

3.  A case of pseudo-Nelson's syndrome: cure of ACTH hypersecretion by removal of a bronchial carcinoid tumor responsible for Cushing's syndrome.

Authors:  J D Lalau; D Vieau; F Tenenbaum; P F Westeel; A Mesmacque; F Lenne; J Quichaud
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

4.  Selective bilateral blood sampling from the inferior petrosal sinus in Cushing's disease: effects of corticotropin-releasing factor and thyrotropin-releasing hormone on pituitary secretion.

Authors:  T R Strack; H H Schild; J Bohl; J Beyer; J Schrezemeir; G Kahaly
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

5.  Retrospective Analysis of Cushing's Disease with or without Hyperprolactinemia.

Authors:  Cheng Huan; Chao Lu; Guang-Ming Xu; Xin Qu; Yuan-Ming Qu
Journal:  Int J Endocrinol       Date:  2014-11-23       Impact factor: 3.257

6.  Diagnostic usefulness of 3 tesla MRI of the brain for cushing disease in a child.

Authors:  Erina Ono; Ayako Ozawa; Kaori Matoba; Takanori Motoki; Asako Tajima; Ichiro Miyata; Junko Ito; Naoko Inoshita; Syozo Yamada; Hiroyuki Ida
Journal:  Clin Pediatr Endocrinol       Date:  2011-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.